Hypokalaemia


  • Statewide logo

    This guideline has been adapted for statewide use with the support of the Victorian Paediatric Clinical Network

  • See also

    Basic Paediatric ECG interpretation
    Dehydration
    Diabetic ketoacidosis (DKA)
    Electrolyte abnormalities 
    Hyperkalaemia
    Intravenous fluids

    Key points

    1. The oral/enteral route is preferred for potassium administration
    2. Intravenous potassium is a high-risk medication and carries risks of inadvertent hyperkalaemia, fluid overload, and peripheral vein extravasation and thrombophlebitis. Rapid intravenous administration or overdose may cause cardiac arrhythmia or arrest 
    3. Monitor fluid status and electrolytes in all children receiving potassium replacement. Children with an initial serum potassium <3.0 mmol/L should have cardiac monitoring, as should those receiving IV replacement
    4. Specialist advice should be sought for critical (K <2.0 mmol/L) or symptomatic hypokalaemia

    Background

    Hypokalaemia is defined as a plasma potassium level less than 3.5 mmol/L

    Severity

    Serum potassium (mmol/L)

    Mild

    3.0-3.4

    Moderate

    2.5-3.0

    Severe

    2.0-2.4

    Critical

    <2.0

    • In normal acid-base status, a 1 mmol/L decrease in serum potassium concentration represents a whole-body deficit of at least 200 mmol. Concurrent metabolic acidosis may falsely elevate the serum potassium and lead to an underestimation of total body deficit. Metabolic alkalosis can have the opposite effect
    • Hypokalaemia is commonly associated with hypomagnesaemia. Serum magnesium should be measured and replaced as required

    Causes of hypokalaemia


    Decreased intake

    Increased losses

    Transcellular shifts

    Medications

    Spurious

    Illness

    Fasting

    Prolonged IV fluids not containing potassium

    Eating disorder

    Poor nutrition

    Gastrointestinal

    • Vomiting
    • Diarrhoea
    • Fistula
    • Laxative overuse

    Renal

    • Osmotic diuresis
    • Aldosterone excess
    • Mineralocorticoid excess
    • Congenital disorders
    • Renal artery stenosis

    Metabolic alkalosis

    Hypomagnesaemia

    Hypernatraemia

    Glucose/insulin administration

    Diabetic ketoacidosis

    Refeeding syndrome

    Loop diuretics eg furosemide

    Thiazide diuretics

    Amphotericin

    Cisplatin

    Insulin

    Beta-agonists eg salbutamol,
    adrenaline

    Sampling error

    • Recent line flush
    • IV fluids near sampling site

      

    Prevention

    In general, children eating a variety of foods will meet their daily potassium requirements (approximately 2-4 mmol/kg/day)

    Consider maintenance fluids containing potassium (see Intravenous fluids) for children who are

    • Nil by mouth and not receiving enteral fluids for prolonged periods, particularly if associated with increased losses
    • At risk of hypokalaemia, see table above for causes

    Assessment

    History

    • Hypokalaemia is often asymptomatic
    • Symptoms of hypokalaemia are more likely when serum levels rapidly decrease to below 3 mmol/L
      • Skeletal muscle weakness, paralysis (in severe cases)
      • Smooth muscle weakness: ileus, constipation, nausea, vomiting
      • Lethargy
      • Fatigue
      • Confusion
      • Polyuria, usually if prolonged hypokalaemia
    • Features of underlying cause
      • Acute diarrhoea/vomiting
      • Decreased intake
      • Use of medications such as salbutamol, diuretics, laxatives
      • History of hypoaldosteronism

    Examination

    • Tachycardia, bradycardia, arrhythmia
    • Fluid status (see Dehydration)
    • Decreased muscle strength, hypotonia and decreased deep tissue reflexes

    Management

    Investigations

    • Repeat potassium to verify initial result
      • Serum potassium level can be falsely elevated in haemolysed/finger prick samples. A venous sample should be taken if clinical suspicion of hypokalaemia
    • Urea, creatinine and electrolytes
    • BGL
    • Venous blood gas
    • Magnesium, especially if hypokalaemia is refractory to treatment (hypomagnesaemia promotes potassium wasting) 
    • ECG: if signs/symptoms of hypokalaemia, risk of cardiac arrhythmia, or serum potassium <3 mmol/L. See Basic Paediatric ECG interpretation
      • Decreased T wave amplitude (usually earliest manifestation)
      • Increased P wave amplitude
      • T wave changes (flattening, inversion)
      • ST changes (usually depression)
      • Appearance of U wave
      • QT prolongation
      • Ventricular ectopic beats
      • Arrhythmia

    Treatment

    Goals of treating hypokalaemia are to

    • Prevent life threatening complications: arrhythmias, paralysis, rhabdomyolysis, diaphragmatic weakness
    • Replace potassium deficit
    • Identify and treat reversible causes, address underlying conditions

    Replacement

    Ensure child is passing urine before commencing potassium replacement

    Potassium replacement is indicated if

    • Serum potassium <3.0 mmol/L

          or

    • Serum potassium <3.5 mmol/L with symptoms, signs and/or ECG changes

    In mild hypokalaemia (serum levels 3.0-3.5 mmol/L), optimal treatment depends on clinical situation. Consider:

    • No acute treatment, monitor electrolytes
    • Increasing maintenance potassium dose
    • Replacing orally/IV if anticipated ongoing losses or inadequate intake

    In children with stable haemodynamics and no ECG changes, aim for a gradual correction over 24-48 hours

    Measure and correct serum magnesium as necessary

    Route of administration

    The oral/enteral route is preferred

    • Potassium is well absorbed from the gastrointestinal tract
    • It is best taken with or soon after food to reduce gastrointestinal irritation

    Intravenous potassium replacement should be considered in

    • a child who is unable to tolerate enteral medication
    • an initial serum potassium <2.5 mmol/L
    • presence of ECG changes

    Oral/enteral dosing

    Dosage

    Acute replacement dose 

    1-2 mmol/kg/dose orally (maximum 20 mmol per dose)
    Dose may be repeated, after checking serum potassium level, to a maximum of 5 mmol/kg/day (maximum total daily dose 50 mmol)

    Maintenance dose
    (if required)

    2-5 mmol/kg/day orally in divided doses (maximum 20 mmol per dose)

    Medication forms

     

    Potassium content

    Notes

    Potassium chloride oral mixture (where available)  

    1.33 mmol/mL  

    • Rapid absorption
    • Expected serum potassium rise after approximately 2 hours

    Effervescent tablet
    eg Chlorvescent®

    14 mmol per tablet    

    • Rapid absorption
    • Ensure tablets are completely dissolved before administration
    • Expected serum potassium rise after approximately 2 hours

    Controlled release enteric coated
    eg Slow K®
    (for maintenance dosing)

    8 mmol per tablet    

    • Slow release, delayed absorption
    • Use for mild or chronic hypokalaemia
    • Tablets must be swallowed whole
    • Expected serum potassium rise after approximately 4 hours

    For acute oral potassium replacement, consider repeat serum potassium level at a time interval guided by the clinical context and the expected serum potassium rise 

    Intravenous dosing

    Dosage

    • Rapid intravenous administration or overdose may cause fatal cardiac arrhythmia or arrest. Administer via an infusion pump using Dose Error Reduction Software (DERS) where available. Note that concentrated potassium solutions should only be administered in critical care settings
    • Include all sources of potassium when calculating replacement doses and infusion rates, eg additives to maintenance fluids, parenteral nutrition, oral/enteral supplements
    • Potassium-containing fluids, including parenteral nutrition, may need to be paused during acute replacement to ensure the maximum rate of potassium administration is not exceeded

    Acute intravenous potassium replacement dose


    Acuity of treating area

    Acute replacement dose

    ECG monitoring required

    Repeat serum potassium level  

    General ward

    0.2 mmol/kg/hour for 3 hours

    (max 10 mmol/hour)

    Note: Dose likely to require intravenous fluid rate greater than maintenance fluid rate

    Only required if serum potassium <3 mmol/L or risk of cardiac arrhythmia  

    1 hour after replacement completion

    Check serum potassium level before administering further replacement

    Critical care area  

    0.4 mmol/kg/hour for 1-2 hours

    (max 20 mmol/hour)

    Note: Likely to require concentrated potassium infusion (see below) and central line

    Yes

    1 hour after replacement commencement
    and
    1 hour after replacement completion

    Maintenance dose (if required):

    • 1-4 mmol/kg/day (max 10 mmol/hour)
    • Doses greater than 4 mmol/kg/day should be discussed with a senior clinician or local retrieval service

    Administration

    Only administer potassium chloride IV by infusion. Never flush after potassium chloride infusions

    Intravenous access

    Potassium concentration

    Dosage form

    Notes

    Peripheral line

    Usual maximum 40 mmol/L
    (discuss with senior clinician if giving 40-60 mmol/L)

    Use premixed fluid bags where possible (various concentrations available)  
     
    When adding potassium chloride to an IV fluid bag, mix well by inverting the bag at least 10 times
    Clearly label all bags, syringes, pumps and lines that contain potassium to avoid inadvertent flushing

    Premixed product 10 mmol potassium chloride in 100 mL 0.29% sodium chloride can be administered via a peripheral line as the product is isotonic due to the reduced sodium content

    Monitor intravenous access site for signs of extravasation or thrombophlebitis       

    Central line

    Concentrations >60 mmol/L must be given via a central line only (maximum rate 0.4 mmol/kg/hour)

    There are several concentrated potassium formulations available
     
    Only administer in areas where there is a clear protocol for administration and monitoring
     
    Contact local retrieval service for further advice
     

    Use should be approved by a senior clinician
     
    ECG monitoring required

    Monitoring

    Ensure regular monitoring of:

    • vital signs
    • clinical and fluid status including urine output
    • any signs of hyperkalaemia (see Hyperkalaemia)
    • IV site for phlebitis or Extravasation

    Consider consultation with local paediatric team when

    • Child requires admission
    • Child requires potassium replacement  

    Consider transfer when

    • Serum potassium <2.0 mmol/L
    • Symptomatic hypokalaemia especially paralysis
    • Significant ECG changes such as arrhythmia, ventricular or supraventricular ectopic beats, ST changes, T wave inversion
    • Renal impairment, including oliguria or high/rising creatinine
    • Risk of arrhythmia
    • Fluid overload
    • Neonates
    • Child with complex medical condition

    For emergency advice and paediatric or neonatal ICU transfers, see Retrieval Services

    Consider discharge when

    • Asymptomatic
    • Potassium >3.0 mmol/L and stable
    • Fluid losses replaced and ongoing replacement possible
    • Plan for ongoing monitoring (ie repeat levels) in place

    Additional information

    ECG: ST depression, T wave inversion, prominent U waves

    ECG-ST

    Last updated October 2024

  • Reference List